Showing results (151-160 of 848) with videos related to
Sort By:
Pageof 85
Orvosi Hetilap|December 31, 1997
[Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients]A Nagy, B Melegh, H LosonczyCanadian Journal of Microbiology|June 1, 1982
The occurrence of filamentous fungi in drinking water distribution systemsL A Nagy, B H OlsonJournal of Neurochemistry|October 1, 1984
Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll)A Nagy, A V Delgado-EscuetaThe Journal of Experimental Medicine|December 1, 1979
The receptor specificity of alloreactive T cells. Distinction between stimulator K, I, and D region products and degeneracy of third-party H-2 recognition by low-affinity T cellsZ A Nagy, B E ElliottOrvosi Hetilap|October 14, 1990
[Causes and management of local tumor recurrence after low resection of the rectum]A Nagy, J Bende, S KarácsonyiAnnals of Human Genetics|May 1, 1984
Assignment of the haemophilia B (factor IX) locus to the q26-qter region of the X chromosomeY Boyd, V J Buckle, E A Munro, et al.Genome Research|March 7, 2001
A novel chromatin immunoprecipitation and array (CIA) analysis identifies a 460-kb CENP-A-binding neocentromere DNAA W Lo, D J Magliano, M C Sibson, et al.Methods in Cell Biology|July 2, 1998
Embryonic stem cells, creating transgenic animalsM Pirity, A K Hadjantonakis, A NagyThe Journal of Molecular and Cellular Immunology : JMCI|January 1, 1986
Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigensP Walden, Z A Nagy, J KleinProceedings of the National Academy of Sciences of the United States of America|March 19, 1996
High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicinA Nagy, P Armatis, A V SchallyPageof 85